Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex
| Brand name | FLUTICASONE PROPIONATE |
| Generic name | FLUTICASONE PROPIONATE |
| Active ingredient(s) | FLUTICASONE PROPIONATE |
| Distributed by / for | Golden State Medical Supply Inc. |
| NDC | 60429-195-15 |
| Full product label | Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: Apotek Inc., Toronto, Ontario, Cananda, Marketed by: GSMS Incorporated, Camarillo, CA, NDC 60429-195-15 |
| Recalling firm | Golden State Medical Supply Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 59,712 bottles |
| Recall initiated | 2024-02-14 |
| Report date | 2024-03-06 |
| Recall completed | — |
| Recall number | D-0349-2024 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Camarillo CA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗